Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diagnostic evaluations of unproven clinical utility in oncology: a real-life example of their harmful consequences.

× No keyword cloud information.

8 in total

1. Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patients.

Authors: K D Hatch; J B Beecham; J A Blessing; W T Creasman
Journal: Cancer Date: 1991-07-15 Impact factor: 6.860

2. Use of positron emission tomography scans in ovarian cancer: a diagnostic technique in search of an indication.

Authors: Maurie Markman
Journal: J Clin Oncol Date: 2005-09-26 Impact factor: 44.544

Review 3. Hormone therapy in epithelial ovarian cancer.

Authors: A P Makar
Journal: Endocr Relat Cancer Date: 2000-06 Impact factor: 5.678

4. Estrogen replacement therapy for ovarian carcinoma survivors: A randomized controlled trial.

Authors: F Guidozzi; A Daponte
Journal: Cancer Date: 1999-09-15 Impact factor: 6.860

5. American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays.

Authors: Deborah Schrag; Harinder S Garewal; Harold J Burstein; David J Samson; Daniel D Von Hoff; Mark R Somerfield
Journal: J Clin Oncol Date: 2004-08-02 Impact factor: 44.544

Review 6. Chemotherapy sensitivity and resistance assays: a systematic review.

Authors: David J Samson; Jerome Seidenfeld; Kathleen Ziegler; Naomi Aronson
Journal: J Clin Oncol Date: 2004-08-02 Impact factor: 44.544

7. Hormone replacement therapy and survival after surgery for ovarian cancer.

Authors: R A Eeles; S Tan; E Wiltshaw; I Fryatt; R P A'Hern; J H Shepherd; C L Harmer; P R Blake; C E Chilvers
Journal: BMJ Date: 1991-02-02

Review 8. Ovarian cancer patients and hormone replacement therapy: a systematic review.

Authors: M L Hopkins; M Fung Kee Fung; T Le; R Shorr
Journal: Gynecol Oncol Date: 2004-03 Impact factor: 5.482

8 in total